Overview
Primary interstitial lung disease in childhood and adulthood due to alveolar structure disorder (Orphanet code 264930) is a group of rare pulmonary conditions characterized by abnormal development or maintenance of the alveolar structures in the lungs. The alveoli are the tiny air sacs where gas exchange occurs, and disruption of their architecture leads to impaired oxygen transfer into the bloodstream. This category encompasses several specific disorders that affect the lung parenchyma, resulting in diffuse interstitial lung disease that can manifest from early childhood through adulthood. Clinical features typically include progressive dyspnea (shortness of breath), tachypnea (rapid breathing), chronic cough, exercise intolerance, and in some cases cyanosis and failure to thrive in children. Chest imaging often reveals diffuse ground-glass opacities, reticular patterns, or other interstitial changes on high-resolution computed tomography (HRCT). Lung biopsy may show characteristic abnormalities in alveolar wall structure, including alveolar simplification, thickened septa, or other architectural distortions. The disease can range from mild respiratory impairment to severe, life-threatening respiratory failure. Treatment is largely supportive and may include supplemental oxygen therapy, pulmonary rehabilitation, and nutritional support. In some cases, corticosteroids or other immunomodulatory agents may be trialed, though evidence for their efficacy in alveolar structure disorders is limited. Hydroxychloroquine has been used in certain pediatric interstitial lung diseases with variable results. For patients with end-stage lung disease, lung transplantation may be considered. The underlying genetic causes vary depending on the specific subtype, and genetic counseling is recommended for affected families. Prognosis is highly variable depending on the specific disorder, severity of alveolar involvement, and age of onset.
Variable
Can be inherited in different ways depending on the underlying gene
Childhood to adulthood
Can begin any time from childhood through adulthood
Treatments
No FDA-approved treatments are currently listed for Primary interstitial lung disease in childhood and adulthood due to alveolar structure disorder.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Primary interstitial lung disease in childhood and adulthood due to alveolar structure disorder at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Primary interstitial lung disease in childhood and adulthood due to alveolar structure disorder.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Primary interstitial lung disease in childhood and adulthood due to alveolar structure disorder.
Community
No community posts yet. Be the first to share your experience with Primary interstitial lung disease in childhood and adulthood due to alveolar structure disorder.
Start the conversation →Latest news about Primary interstitial lung disease in childhood and adulthood due to alveolar structure disorder
No recent news articles for Primary interstitial lung disease in childhood and adulthood due to alveolar structure disorder.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Primary interstitial lung disease in childhood and adulthood due to alveolar structure disorder
What is Primary interstitial lung disease in childhood and adulthood due to alveolar structure disorder?
Primary interstitial lung disease in childhood and adulthood due to alveolar structure disorder (Orphanet code 264930) is a group of rare pulmonary conditions characterized by abnormal development or maintenance of the alveolar structures in the lungs. The alveoli are the tiny air sacs where gas exchange occurs, and disruption of their architecture leads to impaired oxygen transfer into the bloodstream. This category encompasses several specific disorders that affect the lung parenchyma, resulting in diffuse interstitial lung disease that can manifest from early childhood through adulthood. C
At what age does Primary interstitial lung disease in childhood and adulthood due to alveolar structure disorder typically begin?
Typical onset of Primary interstitial lung disease in childhood and adulthood due to alveolar structure disorder is childhood to adulthood. Age of onset can vary across affected individuals.